Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders Equity

v3.24.2.u1
Condensed Consolidated Statements of Stockholders Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Common stock, beginning balance (in shares) at Dec. 31, 2022   622,602,815      
Beginning balance at Dec. 31, 2022 $ 1,164,741 $ 61 $ 1,908,179 $ (734,653) $ (8,846)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (113,393)     (113,393)  
Stock-based compensation 14,157   14,157    
Issuance of common stock upon exercise of stock options (in shares)   945,803      
Issuance of common stock upon exercise of stock options 614   614    
Issuance of common stock upon release of restricted stock units (in shares)   5,836,813      
Vesting of early exercised stock options 104   104    
Issuance of common stock (in shares)   137,174      
Other comprehensive income (loss) 3,272       3,272
Common stock, ending balance (in shares) at Mar. 31, 2023   629,522,605      
Ending balance at Mar. 31, 2023 1,069,495 $ 61 1,923,054 (848,046) (5,574)
Common stock, beginning balance (in shares) at Dec. 31, 2022   622,602,815      
Beginning balance at Dec. 31, 2022 1,164,741 $ 61 1,908,179 (734,653) (8,846)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (399,472)        
Common stock, ending balance (in shares) at Jun. 30, 2023   692,560,949      
Ending balance at Jun. 30, 2023 1,084,552 $ 67 2,223,049 (1,134,125) (4,439)
Common stock, beginning balance (in shares) at Mar. 31, 2023   629,522,605      
Beginning balance at Mar. 31, 2023 1,069,495 $ 61 1,923,054 (848,046) (5,574)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (286,079)     (286,079)  
Stock-based compensation 15,232   15,232    
Issuance of common stock upon exercise of stock options (in shares)   914,077      
Issuance of common stock upon exercise of stock options 679   679    
Issuance of common stock upon release of restricted stock units (in shares)   2,053,991      
Vesting of early exercised stock options 93   93    
Issuance of common stock under the Employee Stock Purchase Plan (in shares)   1,047,001      
Issuance of common stock (in shares)   59,023,275      
Issuance of common stock 280,196 $ 6 280,190    
Issuance of common stock under the Employee Stock Purchase Plan 3,801   3,801    
Other comprehensive income (loss) 1,135       1,135
Common stock, ending balance (in shares) at Jun. 30, 2023   692,560,949      
Ending balance at Jun. 30, 2023 $ 1,084,552 $ 67 2,223,049 (1,134,125) (4,439)
Common stock, beginning balance (in shares) at Dec. 31, 2023 698,262,025 698,262,025      
Beginning balance at Dec. 31, 2023 $ 1,034,362 $ 70 2,282,475 (1,247,703) (480)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (94,587)     (94,587)  
Stock-based compensation 35,328   35,328    
Issuance of common stock upon exercise of stock options (in shares)   1,016,414      
Issuance of common stock upon exercise of stock options 943   943    
Issuance of common stock upon release of restricted stock units (in shares)   6,034,056      
Vesting of early exercised stock options 186   186    
Other comprehensive income (loss) (1,101)       (1,101)
Common stock, ending balance (in shares) at Mar. 31, 2024   705,312,495      
Ending balance at Mar. 31, 2024 $ 975,131 $ 70 2,318,932 (1,342,290) (1,581)
Common stock, beginning balance (in shares) at Dec. 31, 2023 698,262,025 698,262,025      
Beginning balance at Dec. 31, 2023 $ 1,034,362 $ 70 2,282,475 (1,247,703) (480)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (217,879)        
Common stock, ending balance (in shares) at Jun. 30, 2024 713,879,586 713,879,586      
Ending balance at Jun. 30, 2024 $ 894,584 $ 71 2,362,128 (1,465,582) (2,033)
Common stock, beginning balance (in shares) at Mar. 31, 2024   705,312,495      
Beginning balance at Mar. 31, 2024 975,131 $ 70 2,318,932 (1,342,290) (1,581)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (123,292)     (123,292)  
Stock-based compensation 28,441   28,441    
Issuance of common stock upon exercise of stock options (in shares)   424,313      
Issuance of common stock upon exercise of stock options 312 $ 1 311    
Issuance of common stock upon release of restricted stock units (in shares)   3,594,727      
Vesting of early exercised stock options 30   30    
Issuance of common stock under the Employee Stock Purchase Plan (in shares)   1,227,816      
Issuance of common stock (in shares)   3,320,235      
Issuance of common stock 9,472   9,472    
Issuance of common stock under the Employee Stock Purchase Plan 4,942   4,942    
Other comprehensive income (loss) $ (452)       (452)
Common stock, ending balance (in shares) at Jun. 30, 2024 713,879,586 713,879,586      
Ending balance at Jun. 30, 2024 $ 894,584 $ 71 $ 2,362,128 $ (1,465,582) $ (2,033)